These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Typing of E. coli rough strains with phages (author's transl)]. Nimmich W; Straube E; Naumann G Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Dec; 251(1):33-9. PubMed ID: 7036596 [TBL] [Abstract][Full Text] [Related]
9. [Ambivalent bacteriophages of different species active on Escherichia coli K12 and Salmonella sps. strains]. Krylov VN; Miller S; Rachel R; Biebl M; Pletneva EA; Shuetz M; Krylov SV; Shaburova OV Genetika; 2006 Feb; 42(2):159-68. PubMed ID: 16583699 [TBL] [Abstract][Full Text] [Related]
10. A live-attenuated vaccine for the treatment of urinary tract infection by uropathogenic Escherichia coli. Billips BK; Yaggie RE; Cashy JP; Schaeffer AJ; Klumpp DJ J Infect Dis; 2009 Jul; 200(2):263-72. PubMed ID: 19522648 [TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo bacteriolytic activities of Escherichia coli phages: implications for phage therapy. Chibani-Chennoufi S; Sidoti J; Bruttin A; Kutter E; Sarker S; Brüssow H Antimicrob Agents Chemother; 2004 Jul; 48(7):2558-69. PubMed ID: 15215109 [TBL] [Abstract][Full Text] [Related]
12. Uropathogenic Escherichia coli (UPEC) strains may carry virulence properties of diarrhoeagenic E. coli. Abe CM; Salvador FA; Falsetti IN; Vieira MA; Blanco J; Blanco JE; Blanco M; Machado AM; Elias WP; Hernandes RT; Gomes TA FEMS Immunol Med Microbiol; 2008 Apr; 52(3):397-406. PubMed ID: 18336383 [TBL] [Abstract][Full Text] [Related]
13. Blueprinting the regulatory response of Escherichia coli to the urinary tract. Seed PC; Hultgren SJ Trends Microbiol; 2005 Jun; 13(6):246-8. PubMed ID: 15936653 [TBL] [Abstract][Full Text] [Related]
14. Clofibric and ethacrynic acids prevent experimental pyelonephritis by Escherichia coli in mice. Balagué CE; de Ruiz CS; Rey R; de Duffard AM; Nader-Macías ME FEMS Immunol Med Microbiol; 2004 Nov; 42(3):313-9. PubMed ID: 15477045 [TBL] [Abstract][Full Text] [Related]
15. Lysis-deficient bacteriophage therapy decreases endotoxin and inflammatory mediator release and improves survival in a murine peritonitis model. Matsuda T; Freeman TA; Hilbert DW; Duff M; Fuortes M; Stapleton PP; Daly JM Surgery; 2005 Jun; 137(6):639-46. PubMed ID: 15933632 [TBL] [Abstract][Full Text] [Related]
16. A Novel Phage Cocktail Therapy of the Urinary Tract Infection in a Mouse Model. Mijbel Ali B; Gatea Kaabi SA; Al-Bayati MA; Musafer HK Arch Razi Inst; 2021 Nov; 76(5):1229-1236. PubMed ID: 35355758 [No Abstract] [Full Text] [Related]
17. Effect of orally-administered Lactobacillus plantarum LPLM-O1 strain in an immunosuppressed mouse model of urinary tract infection. de Arellano AR; Sánchez M; Vera R; Jara S; González M; Castro E Benef Microbes; 2012 Mar; 3(1):51-9. PubMed ID: 22348909 [TBL] [Abstract][Full Text] [Related]
18. In vivo replication of T4 and T7 bacteriophages in germ-free mice colonized with Escherichia coli. Weiss M; Denou E; Bruttin A; Serra-Moreno R; Dillmann ML; Brüssow H Virology; 2009 Oct; 393(1):16-23. PubMed ID: 19699505 [TBL] [Abstract][Full Text] [Related]